RARE DISEASES A–Z · LETTER F
Fabry Disease
Fabry disease is an inherited lysosomal storage disorder. A missing or faulty enzyme (alpha-galactosidase A) means a fatty substance called Gb3 cannot be broken down and gradually accumulates inside blood vessels, nerves, kidneys, and the heart — damage that builds silently from childhood.
By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026
Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.
The guide
The basics
Gb3 collects first in the walls of small blood vessels, nerves, kidney filters, and heart muscle. Boys typically develop burning pain in the hands and feet — excruciating 'Fabry crises' triggered by fever, exercise, or heat — along with reduced sweating, heat intolerance, clusters of tiny dark-red skin spots (angiokeratomas), gut pain and diarrhoea, and a whorled pattern in the cornea visible on eye examination. With age the deposits thicken the heart (causing breathlessness, rhythm problems, and sometimes being mistaken for other causes of thick heart muscle), scar the kidneys (protein in the urine, then declining function), and raise the risk of early stroke. Women, who have a second X chromosome, are affected more variably — from no symptoms to disease as severe as men's — because of random X-chromosome switching in their cells.
How it works
In men, diagnosis is straightforward: alpha-galactosidase A activity in blood is very low or absent, and a blood or urine test shows raised Gb3-related markers (lyso-Gb3). In women, enzyme activity can be normal, so genetic testing of the GLA gene is the reliable route — and the gene result also predicts whether the tablet (chaperone) treatment can work. Once diagnosed, the team maps organ involvement: kidney function and urine protein, heart MRI and rhythm monitoring, brain imaging where indicated, pain and gut review, and hearing and eye checks. Because Fabry disease is inherited in an X-linked pattern, testing is offered to the wider family — each diagnosis typically uncovers several affected relatives.
Day to day
Two specific treatments replace or rescue the missing enzyme. Enzyme replacement therapy gives the enzyme by intravenous infusion, usually every two weeks, at a centre or at home. A chaperone tablet, taken orally, stabilises the person's own faulty enzyme — but only for the subset of gene variants that produce a rescuable enzyme, which genetic testing determines. Earlier treatment protects organs better, so diagnosis delay is the enemy. Alongside, pain is managed with medicines used for nerve pain (heat and fever triggers are avoided where possible), kidney protection follows standard practice including ACE inhibitor-class medicines for protein leakage, and heart and stroke care follow cardiology guidance. Trials of gene therapy and next-generation enzymes are in progress.
When to get help
Reviews track kidney function and protein, heart size and rhythm, pain control, and stroke risk factors, with imaging at intervals set by your centre. Keep blood pressure, cholesterol, and smoking aggressively managed — the vessels are already vulnerable, so standard risks add up faster. Report new palpitations, fainting, chest pain, or any stroke symptoms immediately. Because pain crises can be mistaken for growing pains, appendicitis, or drug-seeking in undiagnosed young people, families often value a written diagnosis summary for emergency departments. Genetic counselling supports family testing conversations, including testing children, where early knowledge now genuinely changes management.
Common questions
Who was Fabry?
It is named after Johannes Fabry, one of two dermatologists who described the skin changes in 1898. The disease itself is a lysosomal storage disorder — a failure of the cell's recycling machinery — affecting the whole body, not just the skin.
Do women get Fabry disease, or only carry it?
Women were once called 'just carriers', but that is outdated: because X-chromosome inactivation varies, many women develop significant symptoms — pain, and heart and kidney involvement — though usually later and more variably than men. Women need monitoring and, when indicated, treatment in their own right.
Does the tablet treatment work for everyone?
It depends on the variant. The chaperone tablet only works for 'amenable' variants — roughly a third to a half of people with Fabry disease, depending on the population — where the enzyme is made but unstable. Your genetic result determines eligibility; enzyme infusions remain the alternative.
Should my relatives be tested?
Family screening is one of the highest-yield steps in Fabry care: on average several relatives are found for each person diagnosed, often including people with unexplained heart thickening or kidney disease who benefit from earlier treatment.
More in Letter F
Related
Sources
- Fabry Disease — MedlinePlus Genetics (MedlinePlus)
- Fabry Disease (National Organization for Rare Disorders (NORD))
- Fabry Disease — Genetic and Rare Diseases Information Center (NIH GARD)
This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Enzyme and chaperone therapy eligibility depend on your variant and organs involved; follow your metabolic team's plan.